1 October, 2024 16:32:00 IST 
Agarose Bead Technologies (ABT), Spanish manufacturer of agarose resins, has completed a major expansion at its facility located in Northern Spain, Burgos. The 1,000-sqm addition positions ABT as one of Europe’s largest manufacturers of agarose resins, and helps meet the growing global demand for agarose resins in the pharmaceutical and bioprocessing industry.
The Burgos site now boasts two new state-of-the-art cleanroom facilities and has increased its annual capacity to 100,000-litres of resins per year. More storage space will also be available to accommodate large volumes of products.
The expansion comes as ABT solidifies its commitment to supporting the growing needs of biopharmaceutical companies engaged in the development of novel therapies, such as monoclonal antibodies, vaccines, and cell and gene therapies. As these therapies require advanced purification processes, the demand for high-quality agarose resins has surged, and ABT’s expanded capabilities aim to provide critical support to manufacturers worldwide.
“Our investment in expanding the Burgos facility is a direct response to the increasing global demand for high-quality agarose resins,” said Ms. Carolina Egea, CEO of ABT. “This enhanced capacity will enable us to meet the evolving needs of the pharmaceutical industry, improve supply chain reliability, and reinforce our role as a trusted partner in the development of life-saving therapies,” she added.
